---
figid: PMC7484401__nihms-1613153-f0004
figtitle: ANM analysis on long-term PIMi treated cells finds changes in protein complex
  enriched for signaling and growth pathways
organisms:
- Venustaconcha ellipsiformis
- Cosmiometra aster
- Homo sapiens
- Mus musculus
- Moloney murine leukemia virus
pmcid: PMC7484401
filename: nihms-1613153-f0004.jpg
figlink: pmc/articles/PMC7484401/figure/F4/
number: F4
caption: (A) ANM analysis is shown with nodes representing genes and edge length representing
  the strength of the protein-protein interaction, with shorter edge lengths indicating
  higher-weight interactions according to STRING database. The ellipse shaped nodes
  represent genes in either apoptosis, epidermal growth factor receptor tyrosine kinase
  inhibitor resistance (EGFR-TKIR), JAK/STAT, mTOR, NF-kB, or PI3K-AKT signaling pathways.
  The color of the nodes (fill color) indicates the log2(fold change) of the RNA-seq
  expression in AZDR1 cells compared to HSB-2 naive cells. The red fill indicates
  significantly increased (FDR<0.05) proteins and blue fill indicates significantly
  decreased (FDR<0.05) proteins while grey fill indicates not significant (FDR≥0.05).
  The border color of each node represents pathway membership (e.g. yellow bordered
  genes are part of the PI3K-AKT signaling pathway). (B) Enrichment of KEGG pathways
  in active module. The size of the bubble represents gene ratio calculated by taking
  the number of pathway related genes within the active modules divided by the total
  number of genes in the pathway. The significance of the pathway enrichment is measured
  by the FDR (y-axis). Significance is defined as FDR<0.05.
papertitle: 'PIM kinase inhibitors block the growth of primary T-cell acute lymphoblastic
  leukemia: Resistance pathways identified by network modeling analysis.'
reftext: James T. Lim, et al. Mol Cancer Ther. ;19(9):1809-1821.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6134006
figid_alias: PMC7484401__F4
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC7484401__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7484401__nihms-1613153-f0004.html
  '@type': Dataset
  description: (A) ANM analysis is shown with nodes representing genes and edge length
    representing the strength of the protein-protein interaction, with shorter edge
    lengths indicating higher-weight interactions according to STRING database. The
    ellipse shaped nodes represent genes in either apoptosis, epidermal growth factor
    receptor tyrosine kinase inhibitor resistance (EGFR-TKIR), JAK/STAT, mTOR, NF-kB,
    or PI3K-AKT signaling pathways. The color of the nodes (fill color) indicates
    the log2(fold change) of the RNA-seq expression in AZDR1 cells compared to HSB-2
    naive cells. The red fill indicates significantly increased (FDR<0.05) proteins
    and blue fill indicates significantly decreased (FDR<0.05) proteins while grey
    fill indicates not significant (FDR≥0.05). The border color of each node represents
    pathway membership (e.g. yellow bordered genes are part of the PI3K-AKT signaling
    pathway). (B) Enrichment of KEGG pathways in active module. The size of the bubble
    represents gene ratio calculated by taking the number of pathway related genes
    within the active modules divided by the total number of genes in the pathway.
    The significance of the pathway enrichment is measured by the FDR (y-axis). Significance
    is defined as FDR<0.05.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL36RN
  - IL36B
  - IL37
  - IL36A
  - RELB
  - FGF7
  - DDIT4
  - STAT6
  - IL2RB
  - IGF1
  - TNFSF10
  - BIRC3
  - PCK2
  - TRAF1
  - IFNAR1
  - CD40
  - NOS3
  - NANOS3
  - BCL2L11
  - HSP90AB1
  - VEGFA
  - ICAM1
  - VCAM1
  - ITGA1
  - MTOR
  - PIDD1
  - CDKN1A
  - CDPF1
  - JUN
  - JUNB
  - JUND
  - PLAU
  - IFNA17
  - NFKB1
  - NFKB2
  - CYCS
  - FLT3
  - THBS1
  - IGF1R
  - IFNGR1
  - GADD45B
  - CASP3
  - CCND2
  - SOS2
  - EIF4EBP1
  - PTPN6
  - ATM
  - YWHAQ
  - CDK6
  - TNFRSF10A
  - MYC
  - PIAS3
  - PRKCB
  - PIK3CD
  - CLSTN1
  - STAT4
  - LYN
  - MYB
  - CTSH
  - F2R
  - BAX
  - ACTG1
  - TNFAIP3
  - RRAGD
  - RELA
  - REL
  - GSK3B
  - HSP90B1
  - SETD2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - TP53
  - TP63
  - TP73
  - Il36a
  - Relb
  - Fgf7
  - Ddit4
  - Stat6
  - Il2rb
  - Igf1
  - Tnfsf10
  - Birc3
  - Birc2
  - Pck2
  - Traf1
  - Ifnar1
  - Cd40
  - Nos3
  - Nanos3
  - Bcl2l11
  - Hsp90ab1
  - Vegfa
  - Icam1
  - Vcam1
  - Itga1
  - Mtor
  - Pidd1
  - Cdkn1a
  - Jun
  - Plau
  - Nfkb1
  - Cycs
  - Gm10053
  - Flt3
  - Thbs1
  - Igf1r
  - Ifngr1
  - Gadd45b
  - Casp3
  - Ccnd2
  - Sos2
  - Eif4ebp1
  - Ptpn6
  - Atm
  - Tpm1
  - Ywhaq
  - Cdk6
  - Myc
  - Nol3
  - Pias3
  - Prkcb
  - Pik3cd
  - Stat4
  - Lyn
  - Myb
  - Ctsh
  - F2r
  - Bax
  - Nkx3-1
  - Actg1
  - Tnfaip3
  - Rragd
  - Nfkb2
  - Gsk3b
  - Hsp90b1
  - Trp53
  - cancer
  - HTLV-I infection
  - Epstein-Barr virus infection
  - KSHV infection
---
